Authors

• Qingling Zhang (ORCID: https://orcid.org/0000-0002-2433-2849)
• Elizabeth Laws
• Vivian Li (ORCID: https://orcid.org/0000-0003-2041-0085)
• Jennifer Maloney
• Lacey B. Robinson (ORCID: https://orcid.org/0000-0002-0008-2902)
• Sahajal Dhooria (ORCID: https://orcid.org/0000-0003-3199-9163)
• Haohui Fang
• C.-C. Hu (ORCID: https://orcid.org/0009-0004-0605-3792)
• Yi Wang (ORCID: https://orcid.org/0000-0001-6965-9696)
• Jie Lin (ORCID: https://orcid.org/0000-0001-6055-5903)
• Shuyang Zhu (ORCID: https://orcid.org/0000-0002-9998-6476)
• Xiuhua Fu
• Raolat M. Abdulai
• Nanshan Zhong (ORCID: https://orcid.org/0009-0008-7677-2572)

Institutions

• Xuzhou Medical College (CN)
• Regeneron (United States) (US)
• Wenzhou Medical University (CN)
• First Affiliated Hospital of Guangzhou Medical University (CN)
• Sanofi (United States) (US)
• Sanofi (China) (CN)
• State Key Laboratory of Respiratory Disease (CN)
• Xi'an Chest Hospital (CN)
• Inner Mongolia Medical University (CN)
• Post Graduate Institute of Medical Education and Research (IN)
• Guangzhou Medical University (CN)

Publication Details

Journal

Clinical & Experimental Allergy

Published

2025-02-23

DOI

https://doi.org/10.1111/cea.70005

Citations

3

Primary Topic

Asthma and respiratory diseases

Type

article

Field-Weighted Citation Impact

3.49

Funders

• Sanofi
• Regeneron Pharmaceuticals